AGEs, contributors to placental bed vascular changes leading to preeclampsia

Free Radical Research

Volumn 47, Issue S1, 2013, Pages 70-80

  Guedes Martins, L ^a,b,c   Matos, L ^a,b,d   Soares, A ^a,b   Silva, E ^a,b   Almeida, H ^a,b,e  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Institute of Biomedical Sciences Abel Salazar   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e CUF Hospital   (Portugal)

Author keywords

Advanced glycation end products; NF B; Placenta; Preeclampsia; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AGING; AMNION FLUID; BLOOD VESSEL WALL; ENDOTHELIUM; FETUS MEMBRANE; GLYCATION; HUMAN; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REPRODUCTION; REVIEW;

AGING; ANTIGENS, NEOPLASM; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PLACENTA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 84881228672     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.815347     Document Type: Review

References (103)

1. Thornalley PJ , Langborg A , Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344:109-116.
2. Thornalley PJ. The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. Biochem Soc Trans 2003;31:1341-1342.
3. Uribarri J , Tuttle KR. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol 2006;1:1293-1299.
4. Nishikawa T , Edelstein D , Du XL , Yamagishi S , Matsumura T , Kaneda Y , et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
5. Goldin A , Beckman JA , Schmidt AM , Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.
6. Del Turco S , Basta G. An update on advanced glycation endproducts and atherosclerosis. Biofactors 2012;38:266-274.
7. Thornalley PJ , Battah S , Ahmed N , Karachalias N , Agalou S, Babaei-Jadidi R, Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003;375:581-592.
8. Neeper M , Schmidt AM , Brett J , Yan SD , Wang F , Pan YC , et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267:14998-5004.
9. Sugaya K , Fukagawa T , Matsumoto K , Mita K , Takahashi E , Ando A , et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994;23:408-419.
10. Li J , Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997;272:16498-16506.
11. Brett J , Schmidt AM , Yan SD , Zou YS , Weidman E , Pinsky D , et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699-1712.
12. Yan SD , Chen X , Fu J , Chen M , Zhu H , Roher A , et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer ' s disease. Nature 1996;382:685-691.
13. Yonekura H , Yamamoto Y , Sakurai S , Petrova RG , Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370:1097-1109.
14. Raucci A , Cugusi S , Antonelli A , Barabino SM , Monti L , Bierhaus A , et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008;22:3716-3727.
15. Fritz G. RAGE: a single receptor fi ts multiple ligands. T rends Biochem Sci 2011;36:625-632.
16. Xie J , Reverdatto S , Frolov A , Hoffmann R , Burz DS , Shekhtman A. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 2008;283:27255-27269.
17. Hegab Z , Gibbons S , Neyses L , Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol 2012; 4: 90-102.
18. Marenholz I , Heizmann CW , Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004;322:1111-1122.
19. Bianchi ME , Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007;220:35-46.
20. Zhang S , Zhong J , Yang P , Gong F , Wang CY. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol 2009;3:24-38.
21. Haupt C , Bereza M , Kumar ST , Kieninger B , Morgado I , Hortschansky P , et al. Pattern recognition with a fi brilspecifi c antibody fragment reveals the surface variability of natural amyloid fi brils. J Mol Biol 2011;408:529-540.
22. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001; 17: 436-443.
23. Busch M , Franke S , Rster C , Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010;40:742-755.
24. Vlassara H , Li YM , Imani F , Wojciechowicz D , Yang Z , Liu FT , Cerami A. Identifi cation of galectin-3 as a highaffi nity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1995;1:634-646.
25. Jono T , Miyazaki A , Nagai R , Sawamura T , Kitamura T , Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 2002;511:170-174.
26. Uribarri J , Cai W , Peppa M , Goodman S , Ferrucci L , Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to infl ammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007;62:427-433.
27. Schleicher ED , Wagner E , Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457-468.
28. Dalal M , Ferrucci L , Sun K , Beck J , Fried LP , Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci 2009;64:132-137.
29. Yeboah FK , Alli I , Yaylayan VA , Yasuo K , Chowdhury SF , Purisima EO. Effect of limited solid-state glycation on the conformation of lysozyme by ESI-MSMS peptide mapping and molecular modeling. Bioconjug Chem 2004;15:27-34.
30. Yu Y , Hanssen KF , Kalyanaraman V , Chirindel A , Jenkins AJ, Nankervis AJ, et al. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG 2012;119:1512-1520.
31. Kilhovd BK , Berg TJ , Birkeland KI , Thorsby P , Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999;22:1543-1548.
32. Zieman S , Kass D. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail 2004;10:144-149;quiz 150-151.
33. Park L , Raman KG , Lee KJ , Lu Y , Ferran LJ , Chow WS , et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998;4:1025-1031.
34. Obayashi H , Nakano K , Shigeta H , Yamaguchi M , Yoshimori K, Fukui M, et al. Formation of crossline as a fl uorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 1996;226:37-41.
35. Cipollone F , Iezzi A , Fazia M , Zucchelli M , Pini B , Cuccurullo C , et al. The receptor RAGE as a progression factor amplifying arachidonate- dependent infl ammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003; 108: 1070-1077.
36. Yoshida N , Okumura K , Aso Y. High serum pentosidine concentrations are associated with increased arterial stiff ness and thickness in patients with type 2 diabetes. Metabolism 2005;54:345-350.
37. Sims TJ , Rasmussen LM , Oxlund H , Bailey AJ. The role of glycation cross-links in diabetic vascular stiff ening. Diabetologia 1996; 39: 946-951.
38. Nin JW , Jorsal A , Ferreira I , Schalkwijk CG , Prins MH , Parving HH , et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011;34:442-447.
39. Hartog JW , Voors AA , Bakker SJ , Smit AJ , van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 2007;9:1146-1155.
40. Fukami K , Yamagishi S , Ueda S , Okuda S. Role of AGEs in diabetic nephropathy. Curr Pharm Des 2008;14:946-952.
41. Milne R , Brownstein S. Advanced glycation end products and diabetic retinopathy. Amino Acids 2011; 44: 1397-1407.
42. Baumann M. Role of advanced glycation end products in hypertension and cardiovascular risk: human studies. J Am Soc Hypertens 2012;6:427-435.
43. de Leeuw K , Graaff R , de Vries R , Dullaart RP , Smit AJ , Kallenberg CG, Bijl M. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46: 1551-1556.
44. de Groot L , Posthumus MD , Kallenberg CG , Bijl M. Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Invest 2010;40:835-842.
45. Srikanth V , Maczurek A , Phan T , Steele M , Westcott B , Juskiw D, M?ch G. Advanced glycation endproducts and their receptor RAGE in Alzheimer ' s disease. Neurobiol Aging 2011;32:763-777.
46. A , Blood DC , del Toro G , Canet A , Lee DC , Qu W , et al. Blockade of RAGE-Amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354-360.
47. Rojas A , Figueroa H , Morales E. Fueling Inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis 2010;31:334-341.
48. Sibai BM , Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009;200:481.e1-7.
49. Smith SD , Dunk CE , Aplin JD , Harris LK , Jones RL. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009;174:1959-1971.
50. Hazan AD , Smith SD , Jones RL , Whittle W , Lye SJ , Dunk CE. Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol 2010;177:1017-1030.
51. Brosens I , Pijnenborg R , Vercruysse L , Romero R. The " Great Obstetrical Syndromes " are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
52. Sibai B , Dekker G , Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799.
53. Roberts DJ , Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:1254-1260.
54. Barton M. Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pfl ugers Arch 2010; 460:825-837.
55. Martindale JL , Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1-15.
56. Sorci G , Riuzzi F , Giambanco I , Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta 2013;1833:101-109.
57. Bedard K , Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.
58. Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 2007;43:332-347.
59. Takac I , Schrder K , Brandes RP. The Nox family of NADPH oxidases: friend or foe of the vascular system? Curr Hypertens Rep 2012;14:70-78.
60. Thomas SR , Chen K , Keaney JF. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 2002;277:6017-6024.
61. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 2006;46:266-273.
62. Lander HM , Tauras JM , Ogiste JS , Hori O , Moss RA , Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-Activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997;272:17810-17814.
63. Chang PC , Chen TH , Chang CJ , Hou CC , Chan P , Lee HM. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPKdependent pathway. Kidney Int 2004;65:1664-1675.
64. Harja E , Bu DX , Hudson BI , Chang JS , Shen X , Hallam K , et al. Vascular and infl ammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/-mice. J Clin Invest 2008;118:183-194.
65. Karima M , Kantarci A , Ohira T , Hasturk H , Jones VL , Nam BH , et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 2005;78:862-870.
66. Omori K , Ohira T , Uchida Y , Ayilavarapu S , Batista EL , Yagi M , et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292-301.
67. Ayilavarapu S , Kantarci A , Fredman G , Turkoglu O , Omori K , Liu H , et al. Diabetes-induced oxidative stress is mediated by Ca2-independent phospholipase A2 in neutrophils. J Immunol 2010;184:1507-1515.
68. Sick E , Brehin S , AndrP , Coupin G , Landry Y , Takeda K , Gies JP. Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol 2010;161:442-455.
69. Huang JS , Guh JY , Chen HC , Hung WC , Lai YH , Chuang LY. Role of receptor for advanced glycation endproduct (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001;81:102-113.
70. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 2006;58:69-74.
71. Hung TH , Skepper JN , Burton GJ. In vitro ischemiareperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001;159:1031-1043.
72. Knock GA , Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175: 1668-1674.
73. Sankaralingam S , Arenas IA , Lalu MM , Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006;8:1-20.
74. Sargent IL , Germain SJ , Sacks GP , Kumar S , Redman CW. Trophoblast deportation and the maternal infl ammatory response in pre-eclampsia. J Reprod Immunol 2003; 59: 153-160.
75. Mateos-Cceres PJ , Zamorano-Len JJ , Rodrguez-Sierra P , Macaya C, L?ez-Farr?AJ. New and old mechanisms associated with hypertension in the elderly. Int J Hypertens 2012;2012:150107.
76. Han SH , Kim YH , Mook-Jung I. RAGE: the benefi cial and deleterious Effects by diverse mechanisms of actions. Mol Cells 2011;31:91-97.
77. Yan SD , Schmidt AM , Anderson GM , Zhang J , Brett J , Zou YS , et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889-9897.
78. Arumugam T , Simeone DM , Schmidt AM , Logsdon CD. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004;279:5059-5065.
79. Wautier MP , Chappey O , Corda S , Stern DM , Schmidt AM , Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:E685-E694.
80. Wautier JL , Schmidt AM. Protein glycation: a fi rm link to endothelial cell dysfunction. Circ Res 2004;95:233-238.
81. Rojas A , Delgado-Lpez F , Gonzlez I , Prez-Castro R , Romero J, Rojas I. The receptor for advanced glycation endproducts: a complex signaling scenario for a promiscuous receptor. Cell Signal 2013; 25: 609-614.
82. Stitt AW , Curtis TM. Diabetes-related adduct formation and retinopathy. J Ocul Biol Dis Infor 2011; 4: 10-18.
83. Holmlund U , Whmaa H , Bachmayer N , Bremme K , Sverremark-Ekstrm E , Palmblad K. The novel infl ammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta. Immunology 2007;122:430-437.
84. Buhimschi IA , Zhao G , Pettker CM , Bahtiyar MO , Magloire LK, Thung S, et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and Inflammation. Am J Obstet Gynecol 2007;196:181.e1-13.
85. Oliver EA , Buhimschi CS , Dulay AT , Baumbusch MA , Abdel-Razeq SS, Lee SY , et al. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia. J Clin Endocrinol Metab 2011;96:689-698.
86. Cooke CL , Brockelsby JC , Baker PN , Davidge ST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 2003;22:173-184.
87. Chekir C , Nakatsuka M , Noguchi S , Konishi H , Kamada Y , Sasaki A, et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 2006;27:225-233.
88. Konishi H , Nakatsuka M , Chekir C , Noguchi S , Kamada Y , Sasaki A, Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human fi rst trimester trophoblasts. Hum Reprod 2004;19:2156-2162.
89. Feng C , Tao Y , Shang T , Yu M. Calprotectin, RAGE and T k?in hypertensive disorders in pregnancy: expression and signifi cance. Arch Gynecol Obstet 2011;283:161-166.
90. Kwon JH , Kim YH , Kwon JY , Park YW. Clinical signifi cance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia. J Perinat Med 2011;39:507-513.
91. Hjek Z , GermanovA , Kouck M , Zima T , Kopeck P , Vtkova M , et al. Detection of feto-maternal infection/Inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008;36:399-404.
92. GermanovA , Kouck M , Hjek Z , Parzek A , Zima T , KalousovM. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem 2010;43:442-446.
93. Fasshauer M , Seeger J , Waldeyer T , Schrey S , Ebert T , Lossner U , et al. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens 2008;26:1824-1828.
94. Bastek JA , Brown AG , Foreman MN , McShea MA , Anglim LM, Adamczak JE, Elovitz MA. The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth. J Matern Fetal Neonatal Med 2012; 25: 1762-1768.
95. Harsem NK , Braekke K , Torjussen T , Hanssen K , Staff AC. Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens Pregnancy 2008;27:374-386.
96. Naruse K , Sado T , Noguchi T , Tsunemi T , Yoshida S , Akasaka J, et al. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of infl ammatory response. J Reprod Immunol 2012;93:69-74.
97. Wang B , Koga K , Osuga Y , Hirata T , Saito A , Yoshino O , et al. High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia. Am J Reprod Immunol 2011;66:143-148.
98. de Ranitz-Greven WL , Kaasenbrood L , Poucki WK , Hamerling J, Bos DC, Visser GH, et al. Advanced glycation end products, measured as skin autofl uorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus. Diabetes Technol Ther 2012;14:1134-1139.
99. Guosheng L , Hongmei S , Chuan N , Haiying L , Xiaopeng Z , Xianqiong L. The relationship of serum AGE levels in diabetic mothers with adverse fetal outcome. J Perinatol 2009;29:483-488.
100. Perty ska-Marczewska M , G owacka E , Sobczak M , Cypryk K , Wilczy ski J. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol 2009;61:175-182.
101. Williams MA , Enquobahrie DA , Zimmer J , Qiu CF , Hevner K, Abetew D, et al. Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: a pilot study. Clin Lab 2012;58:1045-1050.
102. Romero R , Chaiworapongsa T , Savasan ZA , Hussein Y , Dong Z , Kusanovic JP , et al. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med 2012;25:558-567.
103. Costantine MM , Weiner SJ , Rouse DJ , Hirtz DG , Varner MW , Spong CY , et al. Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death. Int J Dev Neurosci 2011;29:917-922.